GB0614568D0 - Anti-testosterone antibodies - Google Patents

Anti-testosterone antibodies

Info

Publication number
GB0614568D0
GB0614568D0 GBGB0614568.4A GB0614568A GB0614568D0 GB 0614568 D0 GB0614568 D0 GB 0614568D0 GB 0614568 A GB0614568 A GB 0614568A GB 0614568 D0 GB0614568 D0 GB 0614568D0
Authority
GB
United Kingdom
Prior art keywords
testosterone antibodies
testosterone
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0614568.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haptogen Ltd
Original Assignee
Haptogen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haptogen Ltd filed Critical Haptogen Ltd
Priority to GBGB0614568.4A priority Critical patent/GB0614568D0/en
Publication of GB0614568D0 publication Critical patent/GB0614568D0/en
Priority to PCT/GB2007/002764 priority patent/WO2008009960A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0614568.4A 2006-07-21 2006-07-21 Anti-testosterone antibodies Ceased GB0614568D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0614568.4A GB0614568D0 (en) 2006-07-21 2006-07-21 Anti-testosterone antibodies
PCT/GB2007/002764 WO2008009960A2 (en) 2006-07-21 2007-07-20 Anti-testosterone antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0614568.4A GB0614568D0 (en) 2006-07-21 2006-07-21 Anti-testosterone antibodies

Publications (1)

Publication Number Publication Date
GB0614568D0 true GB0614568D0 (en) 2006-08-30

Family

ID=36998533

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0614568.4A Ceased GB0614568D0 (en) 2006-07-21 2006-07-21 Anti-testosterone antibodies

Country Status (2)

Country Link
GB (1) GB0614568D0 (en)
WO (1) WO2008009960A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010537623A (en) * 2007-03-27 2010-12-09 クリストファー ホーヴェンス Methods and compositions for treating prostate cancer
AU2009279378A1 (en) * 2008-08-08 2010-02-11 Niall Corcoran Biological applications of steroid binding domains
ITFI20110140A1 (en) * 2011-07-18 2013-01-19 In Fieri S R L COMPOSITION FOR TOPICAL USE FOR THE TREATMENT OF ALOPECIE
WO2014120975A1 (en) * 2013-02-01 2014-08-07 California Institute Of Technology Antibody-mediated immunocontraception
US10966414B2 (en) 2015-05-26 2021-04-06 California Institute Of Technology Population control using engineered translocations
CN109030811A (en) * 2018-05-31 2018-12-18 湖南远璟生物技术有限公司 A kind of preparation method of testosterone enzyme conjugates
US11965172B2 (en) 2018-11-05 2024-04-23 California Institute Of Technology DNA sequence modification-based gene drive
KR102350655B1 (en) * 2020-10-13 2022-01-12 인센 주식회사 Testosterone-specific Affibody and Uses thereof
CN115521920B (en) * 2022-08-16 2023-06-06 江南大学 Testosterone propionate monoclonal antibody hybridoma cell strain and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies

Also Published As

Publication number Publication date
WO2008009960A2 (en) 2008-01-24
WO2008009960A9 (en) 2008-05-29
WO2008009960A3 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
GB0615662D0 (en) Antibody
GB0708002D0 (en) Antibodies
HK1136970A1 (en) Penta-specific antibody
EP2138576A4 (en) Anti-claudin-4 antibody
EP2076614A4 (en) Synthetic antibodies
PL2059533T3 (en) Multispecific antibodies
IL194892A0 (en) Nonseparation assay methods
PT2011869E (en) Novel anti-cd98 antibody
EP2172483A4 (en) ANTI-Muc17 ANTIBODY
SI2200700T1 (en) Novel antibodies
EP2006379A4 (en) High functional bispecific antibody
EP2021778A4 (en) Nonseparation assay methods
HK1131210A1 (en) Improved immunoassay methods
GB0821100D0 (en) Antibodies
EP2337798A4 (en) Bsa-specific antibodies
GB0718737D0 (en) Antibodies
IL205073A0 (en) Anti-bst2 antibody
GB0702888D0 (en) Novel Antibodies
GB0614568D0 (en) Anti-testosterone antibodies
IL196268A0 (en) Assay methods
GB0818356D0 (en) Antibodies
EP2015785A4 (en) Agrm2 antigen
PT2062053E (en) Improved immunoassay methods
EP2264071A4 (en) Antibody having an immune-enhancement function
GB0720672D0 (en) Assay method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)